← Signal Board

Corcept Therapeutics company information

코셉트 테라퓨틱스NASDAQ:CORT · Nasdaq · Healthcare
$116.23+1.93%
2026-10-02 close

Corcept Therapeutics's company information is shown as of 2026-10-02. It is a security listed on Nasdaq, ticker CORT. There are 10 published related companies.

About this company

Corcept Therapeutics last closed at $116.23 (+1.93%) on 2026-10-02. Signals today: MA aligned, VCP. Listed on Nasdaq.

1 guru reporting 13F holdings — Bridgewater (founded by Ray Dalio)

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F is quarterly and may be filed up to 45 days later.

Curated gurus reporting this holding

A curated subset of well-known investors — not the full institutional ownership.

Suppliers, competitors and related stocks

  • AstraZenecaCompetitor

    쿠싱증후군 등 내분비·희귀질환 치료제 경쟁 가능성이 있는 글로벌 제약사

  • PfizerCompetitor

    중추신경계·내분비·희귀질환 영역에서 경쟁 가능한 대형 제약사

  • NovartisCompetitor

    희귀질환·내분비 치료제 포트폴리오를 가진 글로벌 제약사

  • Bausch HealthCompetitor

    내분비·특수의약품 및 병원 처방 시장에서 경쟁하는 기업

  • RecordatiCompetitor

    희귀질환 치료제 중심으로 쿠싱증후군 치료 시장에서 경쟁 가능

  • Novo NordiskCompetitor

    비만·대사질환 및 스테로이드/대사 관련 영역에서 투자자 관점의 경쟁 테마

  • Endocrine SocietyRelated theme

    내분비질환 치료 트렌드와 처방 확대를 좌우하는 핵심 학회 테마

  • MifepristoneRelated theme

    코셉트의 핵심 약물/성분인 쿠싱증후군 치료 테마

  • Cushing's syndromeRelated theme

    코셉트의 핵심 상업화 대상 질환 테마

  • Janssen PharmaceuticalsCompetitor

    스테로이드·면역·내분비 관련 대형 제약 경쟁사로 볼 수 있는 존슨앤드존슨 계열

Major stocks in the same sector

2026-10-04 dataset

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ $1.2B(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

Corcept Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q